DEPOCYT Safety Questions, DEPOCYT Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about DEPOCYT. Our extensive database of DEPOCYT adverse events and DEPOCYT warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about DEPOCYT
DEPOCYT Safety Reports
Total DEPOCYT reports: 31.DEPOCYT FDA safety alerts: No.
Reported deaths: 4 Reported hospitalizations: 19.
Take DEPOCYT Side Effects Survey or Share Your DEPOCYT Story. DEPOCYT Usage.
Physician from FINLAND reported DEPOCYT problem on Jan 05, 2007. Male patient, 23 years of age, weighting 172.0 lb, was diagnosed with burkitt's lymphoma and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: diplopia, epilepsy, pancytopenia, papilloedema, vision blurred, vith nerve paralysis. DEPOCYT dosage: 50 MG;X2; INTH. During the same period patient was treated with CYTARABINE, METHOTREXATE, SENDOXAN, HOLOXAN, ONCOVIN, DECADRON, RITUXIMAB, DOXORUBICIN. Patient recovered.
DEPOCYT problem was reported by a Consumer or non-health professional from AUSTRIA on Jan 05, 2007. Male patient, 67 years of age, was diagnosed with lymphocytic leukaemia and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: deafness unilateral, tinnitus, vertigo. DEPOCYT dosage: 50 MG;X2;INTH. During the same period patient was treated with MABTHERA, IDARUBICIN, FLUDARABINE, NEUPOGEN. Patient recovered.
Physician from GERMANY reported DEPOCYT problem on Feb 08, 2007. Female patient, 53 years of age, was diagnosed with acute myeloid leukaemia and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: pyrexia. DEPOCYT dosage: 50 MG;QOW;INTH. During the same period patient was treated with LYRICA, FOLIC ACID, FAMVIR, URSODIOL, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
DEPOCYT problem was reported by a Physician from SPAIN on Feb 23, 2007. Male patient, 57 years of age, weighting 169.8 lb, was diagnosed with leukaemia and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: diplopia, dysphonia, febrile neutropenia, headache, monoplegia, neurotoxicity. DEPOCYT dosage: 50 MG;QOW; INTH. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported DEPOCYT problem on Mar 12, 2007. Female patient, 53 years of age, was diagnosed with acute lymphocytic leukaemia recurrent and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: brain oedema, muscular weakness, proctalgia. DEPOCYT dosage: 50 MG;INTH. During the same period patient was treated with TORSEMIDE, LEVOTHYROXINE, LYRICA. Patient was hospitalized. Patient recovered.
DEPOCYT problem was reported by a Physician from GERMANY on Mar 15, 2007. Female patient, 53 years of age, was diagnosed with acute lymphocytic leukaemia recurrent and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: brain oedema, dizziness, muscular weakness, neurotoxicity, proctalgia, progressive multifocal leukoencephalopathy. DEPOCYT dosage: 50 MG; INTH. During the same period patient was treated with TORSEMIDE, LYRICA, GANCICLOVIR, DASATINIB. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported DEPOCYT problem on Mar 27, 2007. Male patient, 76 years of age, was diagnosed with disease recurrence, lymphoma and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: deafness, diabetes insipidus. DEPOCYT dosage: 50 MG; INTH. During the same period patient was treated with MONOPRIL, LUNESTA, FLOMAX, AVELOX, PREDNISONE, ASPIRIN. Patient was hospitalized. Patient recovered.
DEPOCYT problem was reported by a Physician from FRANCE on Apr 12, 2007. Female patient, 54 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: bladder distension, cauda equina syndrome. DEPOCYT dosage: 50 MG. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from AUSTRIA reported DEPOCYT problem on Apr 16, 2007. Male patient, child 5 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: confusional state, disease progression, hallucination, mucosal inflammation, somnolence. DEPOCYT dosage: 35 MG. Patient died.
DEPOCYT problem was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2007. Female patient, 57 years of age, weighting 132.0 lb, was diagnosed with breast cancer, metastases to meninges, metastases to spine and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: asthenia, hypoaesthesia, nerve injury, paralysis. DEPOCYT dosage: unknown. Patient recovered.
Physician from SWITZERLAND reported DEPOCYT problem on June 07, 2007. Male patient, 73 years of age, weighting 169.8 lb, was diagnosed with prophylaxis and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: arachnoiditis. DEPOCYT dosage: 50 MG; X3; INTH. During the same period patient was treated with MABTHERA, CYCLOPHOSPHAMIDE, ADRIAMYCIN PFS, ONCOVIN, DEXAMETHASONE. Patient was hospitalized and became disabled. Patient recovered.
DEPOCYT problem was reported by a Consumer or non-health professional from POLAND on July 03, 2006. Male patient, 61 years of age, was diagnosed with nervous system disorder and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: asthenia, disorientation, disturbance in attention, extrapyramidal disorder, hallucination, visual, meningism, nervous system disorder, pyrexia. DEPOCYT dosage: 50 MG; X1; INTH. During the same period patient was treated with NYSTATIN, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported DEPOCYT problem on Aug 01, 2006. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: facial palsy, facial paresis, hypotonia, quadriparesis, somnolence. DEPOCYT dosage: 50 MG; X2; INTH. Patient recovered.
DEPOCYT problem was reported by a Physician from UNITED STATES on Aug 11, 2006. Female patient was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: abdominal pain, peritonitis. DEPOCYT dosage: 50 MG;. Patient recovered.
Physician from UNITED STATES reported DEPOCYT problem on Aug 16, 2006. Female patient, 58 years of age, was diagnosed with metastases to meninges and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: anaemia, bone marrow failure, disseminated intravascular coagulation, dyspnoea, muscular weakness, thrombocytopenia. DEPOCYT dosage: 50 MG;QOW;INTH. During the same period patient was treated with TEMODAR, DOXIL, ABRAXANE. Patient was hospitalized. Patient recovered.
DEPOCYT problem was reported by a Physician from UNITED STATES on Aug 15, 2006. Female patient, 69 years of age, was diagnosed with nervous system disorder, prophylaxis and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: areflexia, asthenia, decreased appetite, dizziness, eye movement disorder, fatigue, headache, nausea, optic disc haemorrhage. DEPOCYT dosage: 50 MG; INTH. During the same period patient was treated with METHOTREXATE, LEUCOVORIN CALCIUM, PLAQUENIL, PRAVACHOL, CELEBREX, FLEXERIL, CARDIZEM CD. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported DEPOCYT problem on Aug 24, 2006. Female patient, 58 years of age, was diagnosed with metastases to meninges and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: anaemia, asthenia, bone marrow failure, disseminated intravascular coagulation, dyspnoea, muscular weakness. DEPOCYT dosage: 50 MG;QOW;INTH. During the same period patient was treated with TEMODAR, DOXIL, ABRAXANE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
DEPOCYT problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 23, 2006. Male patient, 57 years of age, weighting 198.4 lb, was diagnosed with central nervous system lymphoma and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: blood culture positive, catheter related infection, chills, eczema, escherichia infection, skin inflammation, staphylococcal bacteraemia, staphylococcal infection, vertigo. DEPOCYT dosage: 50 MG;QM;INTH. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISOLONE, DEXAMETHASONE, VINCRISTINE, IMATINIB, METHOTREXATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from reported DEPOCYT problem on Aug 29, 2006. Male patient, 64 years of age, was diagnosed with mantle cell lymphoma and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: asthenia, cauda equina syndrome, encephalomalacia, pain in extremity. DEPOCYT dosage: 50 MG. During the same period patient was treated with CYTARABINE, DEXAMETHASONE, METHOTREXATE. Patient was hospitalized. Patient recovered.
DEPOCYT problem was reported by a Physician from UNITED STATES on Aug 31, 2006. Female patient was diagnosed with central nervous system lymphoma and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: abdominal pain, chemical injury, peritonitis, somnolence. DEPOCYT dosage: 50 MG;. Patient recovered.
Physician from UNITED KINGDOM reported DEPOCYT problem on Sept 05, 2006. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: arachnoiditis, diffuse large b-cell lymphoma, dysaesthesia, facial paresis, headache, malignant neoplasm progression, quadriparesis, somnolence. DEPOCYT dosage: 50 MG; X2; INTH. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.
DEPOCYT problem was reported by a Health Professional from POLAND on Sept 13, 2006. Male patient, 61 years of age, was diagnosed with nervous system disorder and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: arachnoiditis, asthenia, disorientation, disturbance in attention, hallucination, visual, meningism, nervous system disorder, pyrexia. DEPOCYT dosage: 50 MG; X1; INTH. During the same period patient was treated with NYSTATIN, FLUCONAZOLE, DEXAMETHASONE, AMIKACIN, CEFEPIME HYDROCHLORIDE, CEFTRIAXONE. Patient was hospitalized. Patient recovered.
Physician from reported DEPOCYT problem on Sept 21, 2006. Male patient, 64 years of age, was diagnosed with mantle cell lymphoma and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: anal fissure, asthenia, brain oedema, encephalomalacia, hypercholesterolaemia, intervertebral disc protrusion, lumbar vertebral fracture, pain in extremity. DEPOCYT dosage: 50 MG;QM;INTH. During the same period patient was treated with CYTARABINE, DEXAMETHASONE, METHOTREXATE, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.
DEPOCYT problem was reported by a Physician from on Sept 21, 2006. Male patient, 32 years of age, was diagnosed with leukaemia, nervous system disorder and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: anuria, aspartate aminotransferase increased, blister, hypoproteinaemia, hypoxia, interstitial lung disease, neutropenia, oedema, pancytopenia. DEPOCYT dosage: 50 MG; QQW; INTH. During the same period patient was treated with ACYCLOVIR. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported DEPOCYT problem on Oct 04, 2006. Male patient, 32 years of age, was diagnosed with leukaemia and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: anuria, aspartate aminotransferase increased, blister, candidiasis, cytomegalovirus infection, hypertension, hypoproteinaemia, hypoxia, interstitial lung disease. DEPOCYT dosage: unknown. During the same period patient was treated with ACYCLOVIR. Patient was hospitalized. Patient died on 09/27/2006.
DEPOCYT problem was reported by a Physician from UNITED KINGDOM on Oct 17, 2006. Male patient, 32 years of age, was diagnosed with central nervous system leukaemia and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: anuria, aspartate aminotransferase increased, blister, blood culture positive, candidiasis, cytomegalovirus infection, hypertension, hypoproteinaemia, hypoxia. DEPOCYT dosage: 50 MG; QOW; INTH. Patient was hospitalized. Patient died on 09/27/2006.
Consumer or non-health professional from FRANCE reported DEPOCYT problem on Oct 25, 2006. Female patient, 33 years of age, was diagnosed with acute lymphocytic leukaemia, leukaemia recurrent and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: csf protein increased, papilloedema. DEPOCYT dosage: 50 MG; INTH. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
DEPOCYT problem was reported by a Health Professional from UNITED KINGDOM on Dec 21, 2006. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: deafness, tinnitus, vertigo. DEPOCYT dosage: 50 MG;X2;INTH. Patient recovered.
Health Professional from UNITED KINGDOM reported DEPOCYT problem on Dec 19, 2006. Male patient, 23 years of age, was diagnosed with burkitt's lymphoma and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: epilepsy, pupil fixed, vith nerve paralysis. DEPOCYT dosage: 50 MG;X2;INTH. During the same period patient was treated with METHOTREXATE, SENDOXAN, HOLOXAN. Patient recovered.
DEPOCYT problem was reported by a Pharmacist from UNITED STATES on July 05, 2007. Male patient, weighting 183.9 lb, was diagnosed with metastases to meninges and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: convulsion. DEPOCYT dosage: 50 MG ONCE IT. During the same period patient was treated with ATENOLOL, DECADRON, LOTREL, CALCIUM CARBONATE, SENOKOT, MORPHINE, PERCOCET. Patient died on 07/02/2007.
Consumer or non-health professional from UNITED KINGDOM reported DEPOCYT problem on June 25, 2007. Male patient, 23 years of age, weighting 172.0 lb, was diagnosed with burkitt's lymphoma and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: diplopia, epilepsy, neurotoxicity, pancytopenia, papilloedema, vision blurred, vith nerve paralysis. DEPOCYT dosage: 50 MG;X2;INTH. During the same period patient was treated with METHOTREXATE, SENDOXAN, HOLOXAN, ONCOVIN, DECADRON, RITUXAN, DOXORUBICIN. Patient recovered.
This
drug has an active FDA Safety Alert